Stonepine Capital Management, LLC Pmv Pharmaceuticals, Inc. Transaction History
Stonepine Capital Management, LLC
- $103 Billion
- Q1 2025
A detailed history of Stonepine Capital Management, LLC transactions in Pmv Pharmaceuticals, Inc. stock. As of the latest transaction made, Stonepine Capital Management, LLC holds 630,183 shares of PMVP stock, worth $731,012. This represents 0.67% of its overall portfolio holdings.
Number of Shares
630,183
Previous 535,805
17.61%
Holding current value
$731,012
Previous $809 Million
15.1%
% of portfolio
0.67%
Previous 0.65%
Shares
2 transactions
Others Institutions Holding PMVP
# of Institutions
63Shares Held
40.2MCall Options Held
1.8KPut Options Held
100-
Orbimed Advisors LLC San Diego, CA6.48MShares$7.51 Million0.22% of portfolio
-
Bml Capital Management, LLC Zionsville, IN3.75MShares$4.35 Million3.31% of portfolio
-
Sio Capital Management, LLC New York, NY3.74MShares$4.33 Million1.53% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO3.31MShares$3.84 Million0.07% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA3.3MShares$3.83 Million0.29% of portfolio
About PMV Pharmaceuticals, Inc.
- Ticker PMVP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,622,600
- Market Cap $52.9M
- Description
- PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...